A structure--activity study of seven new water soluble nitrosoureas. |
| |
Authors: | J M Heal P Fox P S Schein |
| |
Affiliation: | Division of Medical Oncology, Vincent T. Lombardi Cancer Research Center, Georgetown University School of Medicine, Washington, DC 20007, U.S.A. |
| |
Abstract: | The in vitro alkylating activity, carbamoylating activity, decomposition rates and octanol-water partition coefficients (Log P) of seven water soluble chloroethylnitrosourea antitumor agents and a reference lipid soluble analog were correlated with their biological activities in mice. The alkylating activity of each compound demonstrated a significant inverse linear correlation with both the decomposition rate in 0.1 M sodium phosphate buffer. pH7.4 (r = -0.92,P< 0.01), and the molar ld10 dose (r = 0.87, P< 0.01). A direct relationship was found between the Log P values and both the alkylating activity (r = -0.86. P< 0.01) and the molar ld10 dose (r = 0.77, P< 0.025). However, the addition of the variable. Log P, in multiple regression analysis did not contribute significantly to any of the direct correlations of chemical parameters with biological variables. In comparison, carbamoylating activity did not function as an independent variable for the relative myelotoxicity or lethality of each compound. All water soluble drugs except for chlorozotocin and 1-(2 chloroethyl)-3-(β-d-glucopyranosyl)-1-nitrosourea, the two analogs with glucose carriers, produced a significant reduction in circulating neutrophils at their respective ld10 doses. There was no correlation between relative myelotoxicity and alkylating activity, carbamoylating activity or Log P. The glucose moiety appears to function as an independent variable for reducing nitrosourea cytotoxicity to bone marrow cells without significantly altering antitumor activity. |
| |
Keywords: | Log P logarithm of the distribution coefficients in an octanol-water system dose resulting in death of 10 per cent of normal mice GANU ACNU 1-(2-chloroethyl)-3-(4-amino-2-methylpyrimidine-5-yl) methyl-1 nitrosourea CCNU 1-(2 -chloroethyl) -3 -cyclohexyl -1 nitrosourea DSI 1-(2-chloroethyl)-3-(1 -deoxyscyllo-inositol)-1-nitrosourea TE6 (1,2,3,4/5)-5-[3-(2-chloroethyl)-3-nitrosoureido]-1,2,3,4-cylopentantetrol chlorozotocin To whom reprints requests should be sent: Division of Medical Oncology, Georgetown University Hospital, 3800 Reservoir Road. N.W., Washington. DC 20007. |
本文献已被 ScienceDirect 等数据库收录! |
|